← Back to Clinical Trials
Recruiting Phase 4 NCT06902285

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Trial Parameters

Condition Sleep
Sponsor University of Miami
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 64
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-21
Completion 2026-05-01
Interventions
Magnesium ThreonateControl

Brief Summary

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery

Eligibility Criteria

Inclusion Criteria: * Patients undergoing primary total knee or hip arthroplasty at the University of Miami Hospital * Patients \> 18 years of age * Subjects must be capable of providing informed consent * English or Spanish-speaking Exclusion Criteria: * Previous total joint arthroplasty at the surgical site * History of sleeping disorders, including narcolepsy, sleep apnea, insomnia, parasomnias, and restless leg syndrome. * History of Complex Regional Pain Syndrome in ipsilateral extremity * History of demyelinating disorder or neurologic deficit in the affected extremity * History of psychiatric disorders that could impact sleep, such as untreated depression, bipolar disorder, or schizophrenia. * Participants taking medications known to cause significant sedation or insomnia. * Pregnant or breastfeeding * Being treated for a diagnosis other than primary osteoarthritis (e.g. pelvic/femur fracture) * Patients with known substance use disorder within 6 months of surgery * Liver Failur

Related Trials